Gables Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-250
| Closed | -$16.8K | – | 392 |
|
|
2023
Q4 | $16.8K | Hold |
250
| – | – | 0.01% | 270 |
|
|
2023
Q3 | $16.9K | Hold |
250
| – | – | 0.01% | 255 |
|
|
2023
Q2 | $17.9K | Sell |
250
-35
| -12% | -$2.51K | 0.01% | 262 |
|
|
2023
Q1 | $19.8K | Buy |
285
+35
| +14% | +$2.43K | 0.01% | 251 |
|
|
2022
Q4 | $17K | Hold |
250
| – | – | 0.01% | 253 |
|
|
2022
Q3 | $14K | Hold |
250
| – | – | 0.01% | 255 |
|
|
2022
Q2 | $17K | Hold |
250
| – | – | 0.01% | 262 |
|
|
2022
Q1 | $17K | Hold |
250
| – | – | 0.01% | 263 |
|
|
2021
Q4 | $15K | Hold |
250
| – | – | 0.01% | 278 |
|
|
2021
Q3 | $15K | Hold |
250
| – | – | 0.01% | 279 |
|
|
2021
Q2 | $15K | Hold |
250
| – | – | 0.01% | 280 |
|
|
2021
Q1 | $12K | Hold |
250
| – | – | 0.01% | 310 |
|
|
2020
Q4 | $12K | Hold |
250
| – | – | 0.01% | 302 |
|
|
2020
Q3 | $14K | Buy |
250
+150
| +150% | +$8.4K | 0.01% | 287 |
|
|
2020
Q2 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 318 |
|